View live charts, options flow & technicals for The Cigna Group →
Open Dashboard
The Cigna Group (CI) is a healthcare company in the healthcare plans industry with $282.38B in trailing revenue trading at a 11.3× trailing P/E — analyst consensus: buy.
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Key Statistics
Market Cap
$70.89B
Revenue (TTM)
$282.38B
EPS (TTM)
$23.69
EPS (Fwd est.)
$33.44
Employees
65,669
Trailing P/E
11.32
Forward P/E
8.02
PEG Ratio
0.74
Price / Sales
0.25
Price / Book
1.66
EV / EBITDA
7.51
Beta (5Y)
0.32
Analyst Consensus
Consensus
Buy
Analyst Price Target
+27.3% upside
Target: $341.42
Annual Revenue & Net Income
RevenueNet Income
'22
$179.36B
$6.70B
'23
$194.10B
$5.16B
'24
$246.15B
$3.43B
'25
$273.85B
$5.96B
Earnings History
Quarter
Actual EPS
Estimate
Result
Jul 2026
$7.78
$7.60
Beat (+2.4%)
Apr 2026
$7.79
$7.61
Beat (+2.4%)
Feb 2026
$8.08
$7.88
Beat (+2.5%)
Oct 2025
$7.83
$7.64
Beat (+2.5%)
Next Earnings Report
The Cigna Group is next expected to report earnings on 05 Nov 2026.
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network a…
What is CI's market cap?
The Cigna Group has a market capitalization of approximately $70.89B.
What is CI's P/E ratio?
The Cigna Group trades at a trailing P/E ratio of 11.3x and a forward P/E of 8.0x, which is below the broad market average of ~25x.
How much revenue does CI generate?
The Cigna Group generated $282.38B in trailing 12-month revenue.
What do analysts say about CI?
The analyst consensus rating for The Cigna Group is buy, with a mean price target of $341.42. That implies +27.3% upside from the current price.
When does CI report earnings?
The Cigna Group is next scheduled to report earnings on 05 Nov 2026.
Does CI pay a dividend?
Yes. The Cigna Group pays a dividend with a current yield of 2.28%, at an annual rate of $6.24 per share.
View live charts, options flow, gamma exposure, earnings history, and technical analysis for The Cigna Group on Apsis Markets.
